Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
JAMA. 2021 Sep 14;326(10):926-939. doi: 10.1001/jama.2021.10207.
JAMA. 2021.
PMID: 34519802
Free PMC article.
Clinical Trial.
Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline.
deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I; Parkinson Study Group TEMPO; PRESTO Tyramine Substudy Investigators and Coordinators.
deMarcaida JA, et al.
Mov Disord. 2006 Oct;21(10):1716-21. doi: 10.1002/mds.21048.
Mov Disord. 2006.
PMID: 16856145
Clinical Trial.
Item in Clipboard
Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ; TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators.
Schobel SA, et al.
Neurology. 2017 Dec 12;89(24):2495-2502. doi: 10.1212/WNL.0000000000004743. Epub 2017 Nov 15.
Neurology. 2017.
PMID: 29142089
Free PMC article.
Item in Clipboard
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease.
Olanow CW, Hauser RA, Burdick DJ, Dhall R, de Marcaida JA, Gil RA, Kreitzman DL, Elmer LW, McGarry A, Kieburtz K; P2B Study Group.
Olanow CW, et al. Among authors: de marcaida ja.
Mov Disord. 2024 Feb;39(2):350-359. doi: 10.1002/mds.29642. Epub 2023 Oct 27.
Mov Disord. 2024.
PMID: 37886872
Clinical Trial.
Item in Clipboard
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders Center.
de Marcaida JA, Lahrmann J, Machado D, Bluth L, Dagostine M, Moro-de Casillas M, Bortan E, Kanchana S, Alberts M.
de Marcaida JA, et al.
Geriatrics (Basel). 2020 Sep 18;5(3):54. doi: 10.3390/geriatrics5030054.
Geriatrics (Basel). 2020.
PMID: 32962001
Free PMC article.
Item in Clipboard
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert SM, Kieburtz K, deMarcaida JA, Cohen B, Epstein LG.
McArthur JC, et al.
Arch Neurol. 2004 Nov;61(11):1687-96. doi: 10.1001/archneur.61.11.1687.
Arch Neurol. 2004.
PMID: 15534180
Item in Clipboard
HIV-associated cognitive impairment before and after the advent of combination therapy.
Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L.
Sacktor N, et al. Among authors: de marcaida ja.
J Neurovirol. 2002 Apr;8(2):136-42. doi: 10.1080/13550280290049615.
J Neurovirol. 2002.
PMID: 11935465
Item in Clipboard
Disorders that mimic central nervous system infections.
De Marcaida JA, Reik L Jr.
De Marcaida JA, et al.
Neurol Clin. 1999 Nov;17(4):901-41. doi: 10.1016/s0733-8619(05)70172-9.
Neurol Clin. 1999.
PMID: 10517934
Review.
Item in Clipboard
Cite
Cite